Apnimed, Inc. (NASDAQ:APMD – Get Free Report) major shareholder Morningside Venture Investment acquired 312,500 shares of the business’s stock in a transaction dated Monday, August 3rd. The stock was purchased at an average price of $16.00 per share, for a total transaction of $5,000,000.00. Following the completion of the acquisition, the insider owned 7,152,713 shares in the company, valued at approximately $114,443,408. This trade represents a 4.57% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Apnimed Price Performance
APMD traded up $0.80 on Wednesday, reaching $26.51. 486,065 shares of the company’s stock were exchanged, compared to its average volume of 495,021. Apnimed, Inc. has a twelve month low of $16.12 and a twelve month high of $29.15.
Featured Articles
- Five stocks we like better than Apnimed
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Apnimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apnimed and related companies with MarketBeat.com's FREE daily email newsletter.
